ArticleThe Lancet. Oncology2018

Germline BRCA mutation and outcome in young-onset breast cancer (POSH): a prospective cohort study.

Ellen R Copson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.